Press "Enter" to skip to content

New patent for Sunovion Pharms drug KYNMOBI

0
Copyright © DrugPatentWatch. Originally published at New patent for Sunovion Pharms drug KYNMOBI

Annual Drug Patent Expirations for KYNMOBI
Annual Drug Patent Expirations for KYNMOBI

Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug.

Drug patent litigation for KYNMOBI.

This drug has two hundred and twenty-eight patent family members in twenty-four countries.

The generic ingredient in KYNMOBI is apomorphine hydrochloride. One supplier is listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Sunovion Pharms drug KYNMOBI
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions